97 related articles for article (PubMed ID: 7579414)
1. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies.
Reumaux D; Vossebeld PJ; Roos D; Verhoeven AJ
Blood; 1995 Oct; 86(8):3189-95. PubMed ID: 7579414
[TBL] [Abstract][Full Text] [Related]
2. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.
Sibelius U; Hattar K; Schenkel A; Noll T; Csernok E; Gross WL; Mayet WJ; Piper HM; Seeger W; Grimminger F
J Exp Med; 1998 Feb; 187(4):497-503. PubMed ID: 9463400
[TBL] [Abstract][Full Text] [Related]
3. Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation.
Jerke U; Rolle S; Dittmar G; Bayat B; Santoso S; Sporbert A; Luft F; Kettritz R
J Biol Chem; 2011 Mar; 286(9):7070-81. PubMed ID: 21193407
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of myeloperoxidase G-463/A polymorphism in anti-neutrophil cytoplasmic autoantibody-positive vasculitis.
Rajp A; Adu D; Savage CO
Clin Exp Immunol; 2007 Aug; 149(2):251-6. PubMed ID: 17521322
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.
King WJ; Brooks CJ; Holder R; Hughes P; Adu D; Savage CO
Clin Exp Immunol; 1998 Jun; 112(3):539-46. PubMed ID: 9649227
[TBL] [Abstract][Full Text] [Related]
6. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis.
Hurtado PR; Jeffs L; Nitschke J; Patel M; Sarvestani G; Cassidy J; Hissaria P; Gillis D; Peh CA
BMC Immunol; 2008 Jul; 9():34. PubMed ID: 18625057
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages.
Harper L; Ren Y; Savill J; Adu D; Savage CO
Am J Pathol; 2000 Jul; 157(1):211-20. PubMed ID: 10880391
[TBL] [Abstract][Full Text] [Related]
8. The evolving pathogenesis of systemic vasculitis.
Savage CO
Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.
Chalmers JD; Kettritz R; Korkmaz B
Front Immunol; 2023; 14():1239151. PubMed ID: 38162644
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
Front Immunol; 2021; 12():571933. PubMed ID: 33679731
[TBL] [Abstract][Full Text] [Related]
11. Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis.
Ardizzoni A; Sala A; Colombari B; Giva LB; Cermelli C; Peppoloni S; Vecchiarelli A; Roselletti E; Blasi E; Wheeler RT; Pericolini E
J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33081210
[TBL] [Abstract][Full Text] [Related]
12. Interaction between CD177 and platelet endothelial cell adhesion molecule-1 downregulates membrane-bound proteinase-3 (PR3) expression on neutrophils and attenuates neutrophil activation induced by PR3-ANCA.
Deng H; Hu N; Wang C; Chen M; Zhao MH
Arthritis Res Ther; 2018 Sep; 20(1):213. PubMed ID: 30236159
[TBL] [Abstract][Full Text] [Related]
13. Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils.
Chen SF; Wang FM; Li ZY; Yu F; Chen M; Zhao MH
Front Immunol; 2018; 9():559. PubMed ID: 29616045
[TBL] [Abstract][Full Text] [Related]
14. Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development.
Popat RJ; Hakki S; Thakker A; Coughlan AM; Watson J; Little MA; Spickett CM; Lavender P; Afzali B; Kemper C; Robson MG
JCI Insight; 2017 Jan; 2(2):e87379. PubMed ID: 28138552
[TBL] [Abstract][Full Text] [Related]
15. High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4.
Wang C; Wang H; Chang DY; Hao J; Zhao MH; Chen M
Arthritis Res Ther; 2015 Mar; 17(1):64. PubMed ID: 25889374
[TBL] [Abstract][Full Text] [Related]
16. Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis.
Suzuki K; Suzuki K; Nagao T; Nakayama T
Clin Exp Nephrol; 2013 Oct; 17(5):638-641. PubMed ID: 24072414
[TBL] [Abstract][Full Text] [Related]
17. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
Hao J; Wang C; Yuan J; Chen M; Zhao MH
PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
[TBL] [Abstract][Full Text] [Related]
18. Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
Xiao H; Ciavatta D; Aylor DL; Hu P; de Villena FP; Falk RJ; Jennette JC
Am J Pathol; 2013 Apr; 182(4):1219-26. PubMed ID: 23384999
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-neutrophil interactions in ANCA-associated diseases.
Halbwachs L; Lesavre P
J Am Soc Nephrol; 2012 Sep; 23(9):1449-61. PubMed ID: 22942199
[TBL] [Abstract][Full Text] [Related]
20. High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis.
Cao Y; Yang J; Colby K; Hogan SL; Hu Y; Jennette CE; Berg EA; Zhang Y; Jennette JC; Falk RJ; Preston GA
PLoS One; 2012; 7(8):e42783. PubMed ID: 22880107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
